BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38214811)

  • 1. DADS Inhibits the Proliferation of MDCC-MSB-1 Cells by Inducing Autophagy via the MEK/ERK Signalling Pathway.
    Pan Y; Liu J; Wang D; Zhou P; Chen T; Tang Y; Ji C
    Cell Biochem Biophys; 2024 Mar; 82(1):271-278. PubMed ID: 38214811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway.
    Yue Z; Guan X; Chao R; Huang C; Li D; Yang P; Liu S; Hasegawa T; Guo J; Li M
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31340526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diallyl disulfide induces apoptosis and autophagy via mTOR pathway in myeloid leukemic cell line.
    Suangtamai T; Tanyong DI
    Tumour Biol; 2016 Aug; 37(8):10993-9. PubMed ID: 26891668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ERK and activation of p38 are involved in diallyl disulfide induced apoptosis of leukemia HL-60 cells.
    Tan H; Ling H; He J; Yi L; Zhou J; Lin M; Su Q
    Arch Pharm Res; 2008 Jun; 31(6):786-93. PubMed ID: 18563362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways.
    Yin X; Zhang J; Li X; Liu D; Feng C; Liang R; Zhuang K; Cai C; Xue X; Jing F; Wang X; Wang J; Liu X; Ma H
    Int J Mol Sci; 2014 Jul; 15(7):12422-41. PubMed ID: 25026173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination.
    Xia L; Lin J; Peng M; Jiang X; Peng Q; Cui S; Zhang W; Li S; Wang J; Oyang L; Tan S; Hu Z; Wu N; Tang Y; Luo X; Ren Z; Shi Y; Liao Q; Zhou Y
    Int J Biol Sci; 2024; 20(4):1125-1141. PubMed ID: 38385081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Apoptosis in Human Leukemic Cell Lines by Diallyl Disulfide via Modulation of EGFR/ERK/PKM2 Signaling Pathways.
    Luo N; Zhao LC; Shi QQ; Feng ZQ; Chen DL; Li J
    Asian Pac J Cancer Prev; 2015; 16(8):3509-15. PubMed ID: 25921170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.
    Bauer D; Redmon N; Mazzio E; Taka E; Reuben JS; Day A; Sadrud-Din S; Flores-Rozas H; Soliman KF; Darling-Reed S
    Cytokine; 2015 Sep; 75(1):117-26. PubMed ID: 26100848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma.
    Yin X; Zhang R; Feng C; Zhang J; Liu D; Xu K; Wang X; Zhang S; Li Z; Liu X; Ma H
    Oncol Rep; 2014 Oct; 32(4):1748-56. PubMed ID: 25175641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diallyl disulphide inhibits apolipoprotein(a) expression in HepG2 cells through the MEK1-ERK1/2-ELK-1 pathway.
    Ma X; Liu Y; Tan Y; Qu K; He X; Zhang H; Wang Z
    Lipids Health Dis; 2017 Nov; 16(1):223. PubMed ID: 29178936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis.
    Arunkumar R; Sharmila G; Elumalai P; Senthilkumar K; Banudevi S; Gunadharini DN; Benson CS; Daisy P; Arunakaran J
    Phytomedicine; 2012 Jul; 19(10):912-23. PubMed ID: 22739413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Diallyl Disulfide on the Proliferation and Apoptosis of Epithelial Ovarian Cancer Cells by Inducing G2/M Arrest].
    Zhang RT; Shi HR; Ren F; Liu ZY; Ji PC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Feb; 41(1):43-52. PubMed ID: 30837041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erk is involved in the differentiation induced by diallyl disulfide in the human gastric cancer cell line MGC803.
    Ling H; Zhang LY; Su Q; Song Y; Luo ZY; Zhou XT; Zeng X; He J; Tan H; Yuan JP
    Cell Mol Biol Lett; 2006; 11(3):408-23. PubMed ID: 16874458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl disulfide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells.
    Knowles LM; Milner JA
    J Nutr; 2003 Sep; 133(9):2901-6. PubMed ID: 12949385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress.
    Zeng T; Zhang CL; Song FY; Zhao XL; Yu LH; Zhu ZP; Xie KQ
    Biochim Biophys Acta; 2013 Oct; 1830(10):4848-59. PubMed ID: 23816986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induce defense response of DADS in eggplants during the biotrophic phase of Verticillium dahliae.
    Ali M; Ahmad H; Amin B; Atif MJ; Cheng Z
    BMC Plant Biol; 2022 Apr; 22(1):172. PubMed ID: 35379184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways.
    Yuan JP; Wang GH; Ling H; Su Q; Yang YH; Song Y; Tang RJ; Liu Y; Huang C
    World J Gastroenterol; 2004 Sep; 10(18):2731-4. PubMed ID: 15309729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induction of human prostate carcinoma DU145 cells by diallyl disulfide via modulation of JNK and PI3K/AKT signaling pathways.
    Shin DY; Kim GY; Lee JH; Choi BT; Yoo YH; Choi YH
    Int J Mol Sci; 2012 Nov; 13(11):14158-71. PubMed ID: 23203057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
    Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
    Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
    Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
    Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.